Skip to content

ADVANCE® KTCCNP20Recalls & reported problems

Microport Orthopedics Inc. · ADVANCE® II CoCr TIBIAL BASE NONPOROUS SZ 2 STANDARD · Class 2 · Implant

Adverse event reports
11
Deaths reported
0
Injuries reported
11
Recalls naming it
0

Summary

The FDA's MAUDE database contains 11 adverse event reports that list this exact device (DI M684KTCCNP201), received between Jun 25, 2019 and Mar 21, 2024 — classified as 11 injuries.

The most frequently reported specific device problem is “Loss of Osseointegration” (6 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 1 reportsFeb 2024: 0 reportsMar 2024: 1 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Loss of Osseointegration6
  • Insufficient Device Problem Information2
  • Appropriate Device Problem Term/Code Not Available1
  • Break1
  • Detachment of Device or Device Component1
  • Fracture1

Patient problems

  • Insufficient Information4
  • Bone Fracture(s)2
  • No Information2
  • Unspecified Infection2
  • Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1

Recent adverse event reports

The 11 most recent of 11 reports, in the reporter's own words as published by the FDA.

  • InjuryMar 21, 2024Loss of Osseointegration; Loss of Osseointegration

    ALLEGEDLY, PATIENT WAS REVISED DUE TO ASEPTIC LOOSENING TIBIA. SRNJR NUMBER: (B)(6), SIDE: R, GENDER: F.

    Patient problems: Insufficient Information

    MAUDE report 18955517 ↗
  • InjuryJan 23, 2024Loss of Osseointegration; Loss of Osseointegration

    ALLEGEDLY, PATIENT UNDERWENT LEFT TKA ON (B)(6) 2018 AND WAS IMPLANTED WITH ADVANCE POST STAB FEMORAL. PATIENT WAS REVISED ON (B)(6) 2023 DUE TO ASEPTIC LOOSENING. FEMORAL COMPONENT, TIBIAL COMPONENT, TIBIAL LINER ALL REMOVED.

    Patient problems: Insufficient Information

    MAUDE report 18565271 ↗
  • InjuryApr 12, 2023Insufficient Device Problem Information; Insufficient Device Problem Information

    ALLEGEDLY, PATIENT WAS REVISED DUE TO PERI-PROSTHETIC FRACTURE. REVISION NJR NUMBER: 5050346. SIDE: L . PRIMARY ASA: P2 - MILD DISEASE NOT INCAPACITATING. PRODUCT NO REVISED: PRODUCT ID: KPONTP32, ADVANCE ONLAY ALL POLY PATELLA 32MM TRIPEG, LOT: 177967, QTY: 1.

    Patient problems: Bone Fracture(s)

    MAUDE report 16726462 ↗
  • InjuryApr 12, 2023Loss of Osseointegration; Loss of Osseointegration

    ALLEGEDLY, PATIENT WAS REVISED DUE TO ASEPTIC LOOSENING TIBIA. REVISION NJR NUMBER: 5069778. SIDE: R. PRIMARY ASA: P2 - MILD DISEASE NOT INCAPACITATING.

    Patient problems: Insufficient Information

    MAUDE report 16725348 ↗
  • InjuryJan 31, 2022Fracture

    ALLEGEDLY, PATIENT WAS REVISED DUE TO PERI-PROSTHETIC FRACTURE. NO REVISED: PART ID KPONTP35, ADVANCE ONLAY ALL POLY PATELLA 35MM TRIPEG, LOT 29792865, QTY 1. REVISION NJR NUMBER: (B)(6). SIDE: R. PRIMARY ASA: P2 - MILD DISEASE NOT INCAPACITATING.

    Patient problems: Bone Fracture(s)

    MAUDE report 13400866 ↗
  • InjuryMay 10, 2021Break; Break

    ALLEGEDLY, PATIENT WAS REVISED DUE TO IMPLANT FRACTURE. REVISION NJR NUMBER: (B)(4). SIDE: L. PRIMARY ASA: P3 - INCAPACITATING SYSTEMIC DISEASE. MHRA REFERENCE NO: (B)(4).

    Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available

    MAUDE report 11803416 ↗
  • InjuryMar 3, 2021Appropriate Device Problem Term/Code Not Available

    ALLEGEDLY, PATIENT WAS REVISED DUE TO INFECTION. REVISION NJR NUMBER: (B)(4). SIDE: L. PRIMARY ASA: P2 - MILD DISEASE NOT INCAPACITATING. MHRA REFERENCE NO: (B)(4).

    Patient problems: Unspecified Infection

    MAUDE report 11404533 ↗
  • InjuryFeb 9, 2021Loss of Osseointegration; Loss of Osseointegration

    ALLEGEDLY, PATIENT WAS REVISED DUE TO ASEPTIC LOOSENING TIBIA. REVISION NJR NUMBER: (B)(4). SIDE: L. PRIMARY ASA: P2 - MILD DISEASE NOT INCAPACITATING. (B)(6).

    Patient problems: Insufficient Information

    MAUDE report 11304726 ↗
  • InjuryDec 7, 2020Loss of Osseointegration; Detachment of Device or Device Component; Loss of Osseointegration; Detachment of Device or Device Component

    ALLEGEDLY, TIBIAL INSERT WAS FOUND TO BE LOOSE FROM THE TIBIAL BASE. PATIENT HAD HER FIRST REVISION ON (B)(6) 2020, IT WAS CAPTURED UNDER INCIDENT NUMBER: (B)(4).

    Patient problems: No Information

    MAUDE report 10961831 ↗
  • InjuryOct 9, 2020Loss of Osseointegration; Loss of Osseointegration

    ALLEGEDLY, PATIENT WAS REVISED DUE TO ASEPTIC LOOSENING FEMUR , ASEPTIC LOOSENING TIBIA , LYSIS FEMUR AND LYSIS TIBIA. REVISION NJR NUMBER: (B)(4), SIDE:L, PRIMARY ASA: P2 - MILD DISEASE NOT INCAPACITATING.

    Patient problems: No Information

    MAUDE report 10658598 ↗
  • InjuryJun 25, 2019Insufficient Device Problem Information; Insufficient Device Problem Information

    ALLEGEDLY THE PATIENT WAS REVISED DUE TO INFECTION. REVISION NJR NUMBER: (B)(4), SIDE: L, PRIMARY ASA: P3- INCAPACITATING SYSTEMIC DISEASE.

    Patient problems: Unspecified Infection

    MAUDE report 8732930 ↗

Other Prosthesis, Knee, Femorotibial, Semi-Constrained, Cemented, Metal/Polymer devices

All Prosthesis, Knee, Femorotibial, Semi-Constrained, Cemented, Metal/Polymer devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.